These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18482055)

  • 1. Simple, defensible sample sizes based on cost efficiency.
    Bacchetti P; McCulloch CE; Segal MR
    Biometrics; 2008 Jun; 64(2):577-85; discussion 586-94. PubMed ID: 18482055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal allocation of sample sizes to multicenter clinical trials.
    Lai D; Chang KC; Rahbar MH; Moye LA
    J Biopharm Stat; 2013; 23(4):818-28. PubMed ID: 23786227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Power and sample size calculations for stochastic cost-effectiveness analysis.
    Briggs AH; Gray AM
    Med Decis Making; 1998; 18(2 Suppl):S81-92. PubMed ID: 9566469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breaking free of sample size dogma to perform innovative translational research.
    Bacchetti P; Deeks SG; McCune JM
    Sci Transl Med; 2011 Jun; 3(87):87ps24. PubMed ID: 21677197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimize the use of minimization with unequal allocation.
    Proschan M; Brittain E; Kammerman L
    Biometrics; 2011 Sep; 67(3):1135-41. PubMed ID: 21281276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal design of longitudinal data analysis using generalized estimating equation models.
    Liu J; Colditz GA
    Biom J; 2017 Mar; 59(2):315-330. PubMed ID: 27878852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The net effect of alternative allocation ratios on recruitment time and trial cost.
    Vozdolska R; Sano M; Aisen P; Edland SD
    Clin Trials; 2009 Apr; 6(2):126-32. PubMed ID: 19342464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sample size formula for the supremum log-rank statistic.
    Eng KH; Kosorok MR
    Biometrics; 2005 Mar; 61(1):86-91. PubMed ID: 15737081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous treatment effects in stratified clinical trials with time-to-event endpoints.
    Beisel C; Benner A; Kunz C; Kopp-Schneider A
    Biom J; 2017 May; 59(3):511-530. PubMed ID: 28263395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size calculation for the van Elteren test adjusting for ties.
    Zhao YD; Rahardja D; Mei Y
    J Biopharm Stat; 2008; 18(6):1112-9. PubMed ID: 18991111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of adaptive designs: efficiency evaluation.
    Menon S; Chang M
    J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal and maximin sample sizes for multicentre cost-effectiveness trials.
    Manju MA; Candel MJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):513-39. PubMed ID: 25656551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the effective sample size of a parametric prior.
    Morita S; Thall PF; Müller P
    Biometrics; 2008 Jun; 64(2):595-602. PubMed ID: 17764481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A behavioral Bayes method to determine the sample size of a clinical trial considering efficacy and safety.
    Kikuchi T; Gittins J
    Stat Med; 2009 Aug; 28(18):2293-306. PubMed ID: 19536745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The choice of sample size: a mixed Bayesian / frequentist approach.
    Pezeshk H; Nematollahi N; Maroufy V; Gittins J
    Stat Methods Med Res; 2009 Apr; 18(2):183-94. PubMed ID: 18445695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Power and sample size for ordered categorical data.
    Rabbee N; Coull BA; Mehta C; Patel N; Senchaudhuri P
    Stat Methods Med Res; 2003 Jan; 12(1):73-84. PubMed ID: 12617509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data.
    Willan AR; O'Brien BJ
    Health Econ; 1999 May; 8(3):203-11. PubMed ID: 10348415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.